Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Autoimmune diseases require precise immunomodulation due to chronic and systemic effects.
• Traditional therapies face challenges in targeted delivery and managing side effects.

Purpose of the Study:

• To review biodegradable and stimuli-responsive nanocarriers for targeted autoimmune disease therapy.
• To analyze mechanisms, applications, and clinical translation challenges of these nanomaterials.

Main Methods:

• Comprehensive analysis of state-of-the-art biodegradable nanocarriers (nanoparticles, liposomes, hydrogels).
• Discussion of stimuli-responsive release mechanisms (pH, temperature, redox, enzymatic).
• Review of applications in rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.

Main Results:

• Nanomaterials enable localized and controlled release of anti-inflammatory and immunosuppressive agents.
• Targeted delivery minimizes systemic toxicity and enhances therapeutic outcomes.
• Successful applications demonstrated in preclinical models of autoimmune conditions.

Conclusions:

• Biodegradable, stimuli-responsive nanomaterials show transformative potential for autoimmune disease management.
• These systems are key to advancing precision medicine and improving patient outcomes.
• Further research is needed to address biocompatibility, scalability, and regulatory challenges for clinical translation.